TabsDetailsEvent InformationDate: Tuesday, September 6, 2011Event Type: WorkshopDescription: On September 7, the Engelberg Center hosted the first of the three-part Sentinel Initiative 101 Webinar Series, “Overview of FDA’s Sentinel Initiative” to review ongoing activities and accomplishments. The roundtable featured a presentation from Dr. Judy Racoosin, Sentinel Initiative Scientific Lead, Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration.Dr. Racoosin’s presentation provided a high-level review of the Sentinel Initiative’s scope and achievements including:FDA’s 3-year vision for the Sentinel InitiativeA brief overview of the role of the Mini-Sentinel pilot, the Observational Medical Outcomes Partnership, the Federal Partners Collaboration, and the Brookings Institution cooperative agreementNext steps for the Sentinel Initiative Read More Event Materials: https://www.brookings.edu/events/brookings-roundtable-on-active-medical-product-surveillance-overview-of-fdas-sentinel-initiative/Additional InformationInformationHost: Mark McClellan MD, PhD, MPA; Engelberg Center for Health Care Reform, Brookings Institution, Washington, DCRelated Assessment(s): https://www.brookings.edu/events/brookings-active-surveillance-implementation-co…ContributorsPresenter(s): Judy Racoosin MD, MPH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Springs, MD
